Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
9341.T
BUYGENOVA, Inc. · Healthcare · Japan · $60M · Avg Vol: $246K/d
75
StockRankQ
72
V
44
M
46
P/E (TTM)
35.6x
ROE
4.0%
D/E
0.1x
Dividend %
—
COMPANY DESCRIPTION
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 30M | 41M | 54M | 63M | 27.7% |
| EPS | 0.27 | 0.48 | 0.61 | 0.50 | 22.9% |
| Shares | 17M | 18M | 18M | 18M | +5.3% |
| Debt | 1M | 176,596 | 2M | 130,257 | -49.7% |
| Equity | 9M | 25M | 38M | 44M | 67.6% |
| Op CF | 4M | 8M | 11M | 7M | 24.2% |
| Inv CF | -1M | -709,271 | -589,161 | -2M | — |
| Fin CF | 374,391 | 7M | 2M | -6M | — |
Loading...
PRICE (1M)+4.3%
SMA 50SMA 200
Close
$3.64
RSI (14)
50.0
52W High
$4.48
From 52W High
0.8%
SCORE BREAKDOWN
Quality
72
ROIC
28.7%96.1
ROE
4.0%53.4
GP/Assets
75.9%94.6
Op. Margin
11.7%69.4
FCF/Assets
3.2%63.0
Piotroski
—55.7
Int. Cover
50.0x91.5
D/E Ratio
0.11x65.0
Current Ratio
3.73x61.6
Value
44
P/E (TTM)
35.6x30.4
EV/EBITDA
9.2x45.0
P/FCF
5578.9x32.7
P/B
1.4x67.9
P/S
0.8x86.6
Div Yield
—N/A
Momentum
46
52W High %
81%76.0
RS 6M
-32%39.4
SMA 50/200
0.98x58.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-31%17.4
FUNDAMENTALS
Market Cap
$60M
P/E (Forward)
—
Gross Margin
55.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 9341.T are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 9341.T | GENOVA, Inc.(you) | $60M | 75 | BUY |
| 7963.T | Koken Ltd. | $56M | 66 | BUY |
| 5187.T | Create Medic Co., Ltd. | $57M | 90 | STRONG BUY |
| 6678.T | Techno Medica Co., Ltd. | $84M | 88 | STRONG BUY |
| 7792.T | Colan Totte.Co.,Ltd. | $82M | 99 | STRONG BUY |
| 7600.T | Japan Medical Dynamic Marketing, INC. | $129M | 90 | STRONG BUY |
| 4548.T | Seikagaku Corporation | $265M | 76 | BUY |
| 6823.T | Rion Co., Ltd. | $273M | 99 | STRONG BUY |
| 4549.T | Eiken Chemical Co., Ltd. | $615M | 62 | HOLD |
| 6523.T | PHC Holdings Corporation | $805M | 88 | STRONG BUY |
Peer medians: ROE 8.4% · P/E 15.5x · Gross margin 47.8%